Exactech Awarded National Contract from HealthTrust Purchasing Group for Orthopaedic Products

Three year contract covers Exactech’s Equinoxe® shoulder product line

GAINESVILLE, Fla. -- Exactech Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it has been awarded a national purchasing contract by HealthTrust Purchasing Group (HealthTrust). This contract will cover the Equinoxe® Shoulder product line. The award is a three-year agreement that goes into effect August 1, 2008.

“This contract will enable Exactech to continue its impressive growth in the shoulder product line, while providing HealthTrust with a great savings opportunity,” says Devin Childers, sales manager at Exactech.

Exactech vice president of Sales, Bob Purcell says, “This new award offers Exactech an excellent opportunity to better work with the hospitals in the HealthTrust organization. Together with the recently announced hip and knee products award, this contract provides yet broader exposure for Exactech’s orthopaedic products.”

About HealthTrust Purchasing Group
HealthTrust Purchasing Group, LP, headquartered in Brentwood, Tennessee, is a group purchasing organization that supports over 1400 not-for-profit and for-profit acute care facilities, as well as ambulatory surgery centers, physician practices, and alternate care sites. With an annual purchasing volume by its members of more than $13 billion, HealthTrust is committed to obtaining the best price for clinically-recommended products, ensuring their timely delivery and continuously evaluating and improving its services to the patients, physicians and clinicians it serves. HealthTrust is located at 155 Franklin Road, Suite 400, Brentwood, TN 37027. More information about HealthTrust can be found at: www.healthtrustpg.com.

About Exactech
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States and Australia, in addition to more than 30 markets in Europe, Asia and Latin America. Additional information about Exactech, Inc. can be found at www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at www.exac.com and www.hawkassociates.com.

An investment profile on Exactech may be found at www.hawkassociates.com/profile/exac.cfm.

Investors may contact Chief Financial Officer Jody Phillips at 352-377-1140 or Julie Marshall or Frank Hawkins, Hawk Associates Inc., at 305-451-1888, e-mail: exactech@hawkassociates.com. To receive future releases in e-mail alerts, sign up at www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

PDF